Prospective Pecutaneous Coronary Intervention Registry

Recruiting

• Conditions: Coronary Artery Disease; Percutaneous Coronary Intervention
• Interventions: Procedure: Percutaneous coronary intervention

• Registration Number: NCT05624905
• Lead Sponsor: Samsung Medical Center

Brief Summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-03-20
• Study First Submitted: 2022-11-15
• Study First Submitted QC: 2022-11-15
• Study First Posted: 2022-11-22
• Status Verified: 2024-08
• Last Update Submitted: 2024-08-12
• Last Update Posted: 2024-08-14
• Primary Completion: 2030-12-31
• Study Completion: 2030-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 15000

Inclusion Criteria

• patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.

Exclusion Criteria

• patients who did not consent to the research

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
PCI group	Percutaneous coronary intervention	All consecutive patients with coronary artery disease who underwent percutaneous coronary intervention

Primary Outcome Measures

Name	Time	Method
Rates of Cardiac death or Target-vessel myocardial infarction	up to 10 years	A composite of cardiac death or target vessel myocardial infarction
Rates of Major adverse cardiac and cerebrovascular event	up to 10 years	A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization

Secondary Outcome Measures

Name	Time	Method
Rates of cardiac death	up to 10 years	Death from cardiac cause
Rates of all-cause death	up to 10 years	Death from any cause
Rates of target lesion revascularization	up to 10 years	target lesion revascularization
Rates of target vessel revascularization	up to 10 years	target vessel revascularization
Rates of cerebrovascular accident	up to 10 years	ischemic or hemorrhagic stroke
Rates of stent thrombosis	up to 10 years	definite or probable stent thrombosis
Rates of myocardial infarction	up to 10 years	Any myocardial infarction
Rates of target-vessel myocardial infarction	up to 10 years	target-vessel myocardial infarction

Trial Locations

Locations (1)

Samsung Medical Center; 🇰🇷 Seoul, Korea, Republic of